Publication | Closed Access

Self-controlled release of Oxaliplatin prodrug from d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) functionalized mesoporous silica nanoparticles for cancer therapy

NanomedicineNanotherapeuticsMesoporous Silica NanoparticlesEngineeringNanomaterialsSelf-controlled ReleasePolymer-drug ConjugateTherapeutic NanomaterialsDrug Delivery SystemsOxaliplatin ProdrugNano-drug DeliveryDrug Delivery SystemMedicineBiomolecular Engineering